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Abstract
Phospholipase C-η2 (PLC-η2) was recently identified as a novel broadly expressed phosphoinositide-
hydrolyzing isozyme [Zhou, Y., et al. (2005) Biochem. J. 391, 667–676; Nakahara, M., et al. (2005)
J. Biol. Chem. 280, 29128–29134]. In this study, we investigated the direct regulation of PLC-η2 by
Gβγ subunits of heterotrimeric G proteins. Coexpression of PLC-η2 with Gβ1γ2, as well as with
certain other Gβγ dimers, in COS-7 cells resulted in increases in inositol phosphate accumulation.
Gβ1γ2-dependent increases in phosphoinositide hydrolysis also were observed with a truncation
mutant of PLC-η2 that lacks the long alternatively spliced carboxy-terminal domain of the isozyme.
To begin to define the enzymatic properties of PLC-η2 and its potential direct activation by Gβγ, a
construct of PLC-η2 encompassing the canonical domains conserved in all PLCs (PH domain through
C2 domain) was purified to homogeneity after expression from a baculovirus in insect cells. Enzyme
activity of purified PLC-η2 was quantified after reconstitution with PtdIns(4,5)P2-containing
phospholipid vesicles, and values for Km (14.4 µM) and Vmax [12.6 µmol min−1 (mg of protein)−1]
were similar to activities previously observed with purified PLC-β or PLC-ε isozymes. Moreover,
purified Gβ1γ2 stimulated the activity of purified PLC-η2 in a concentration-dependent manner
similar to that observed with purified PLC-β2. Activation was dependent on the presence of free
Gβ1γ2 since its sequestration in the presence of Gαi1 or GRK2-ct reversed Gβ1γ2-promoted
activation. The PH domain of PLC-η2 is not required for Gβ1γ2-mediated regulation since a purified
fragment encompassing the EF-hand through C2 domains but lacking the PH domain nonetheless
was activated by Gβ1γ2. Taken together, these studies illustrate that PLC-η2 is a direct downstream
effector of Gβγ and, therefore, of receptor-activated heterotrimeric G proteins.
Physiological responses to a variety of extracellular stimuli result from phospholipase C-
catalyzed conversion of the minor membrane phospholipid PtdIns(4,5)P2 1 into the Ca2+-
mobilizing second messenger, Ins(1,4,5)P3, and the protein kinase C-activating second
messenger, diacylglycerol (1,2). Membrane inositol lipids specifically bind to conserved PH,
FYVE, PX (phox), and other domains found in key proteins in a broad range of signaling
pathways (3,4). Thus, by altering the ratio of membrane phosphoinositides, PLC isozymes also
affect membrane association and activity of many signaling proteins.
A large family of PLC isozymes exists that includes six subfamilies of PLC (PLC-β, -γ, -δ, -
ζ, -ε, and -η) and a total of 13 members (5). All PLC isozymes contain canonical PH, EF-hand,
catalytic TIM barrel, and C2 domains, with the exception of sperm-specific PLC-ζ (6), which
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lacks a PH domain. PLC-δ isozymes are broadly distributed, but a description of their
mechanism of regulation remains elusive (5). PLC-γ isozymes contain SH2 and SH3 (Src
homology 2 and 3, respectively) domains and are regulated by receptor and nonreceptor
tyrosine kinases (5,7–10). PLC-γ2 also was shown recently to be regulated by Rac GTPases
(11). PLC-β isozymes are elaborated with a helical C-terminus (12) and are activated directly
by Gα subunits of the Gq family of heterotrimeric G proteins (13–15). Gβγ dimers released
from heterotrimeric G proteins of the Gi family also activate PLC-β2 and PLC-β3 (16–18).
Rac GTPases bind to the PH domain and activate PLC-β2 (19,20), and a crystal structure of
Rac in GTP-dependent complex with PLC-β2 has provided new insight into the molecular
mechanism of G protein-mediated regulation of PLC-β isozymes (21). PLC-ε contains a
CDC25 guanine nucleotide exchange factor domain at the amino terminus and two tandem RA
domains at the carboxy terminus. Ras and Rho GTPases bind to the RA domains and the
catalytic core, respectively, and directly regulate the activity of PLC-ε by distinct mechanisms
(22–27).
Four research groups recently reported identification of a pair of novel PLC isozymes, PLC-
η1 and PLC-η2 (28–31). PLC-η2 contains a long alternatively spliced variably expressed
carboxy terminus (31), and the mouse ortholog was proposed to be involved in developmental
aspects of neuronal function (30). We now illustrate that PLC-η2 is directly activated by
Gβγ subunits of heterotrimeric G proteins by a mechanism that requires the canonical catalytic
core of the isozyme.
MATERIALS AND METHODS
Materials
Inositol-free medium was purchased from ICN Biochemicals (Costa Mesa, CA).
[inositol-2-3H]Phosphatidylinositol 4,5-bisphosphate substrate was purchased from Perkin-
Elmer (Boston, MA), and brain L-α-phosphatidylinositol 4,5-bisphosphate and bovine liver L-
α-phosphatidylethanolamine were purchased from Avanti Polar Lipids (Alabaster, AL).
Protease inhibitor tablets were obtained from Roche Applied Science (Madison, WI). All other
reagents were from sources previously reported (31).
We previously determined that 23 exons encode human PLC-η2 (31). DNA sequence of human
PLC-η2 corresponding to exons 2–23 and amino acids 42–1416 [PLC-η2(2–23)] or
corresponding to amino acids 42–872 [PLC-η2(PH-C2)] was cloned into the pcDNA3.1 vector
at the 5′ EcoRI and 3′ XbaI sites. PLC-η2(2–23) was also cloned into the pcDNA4 vector with
5′ EcoRI and 3′ AgeI sites with a carboxy-terminal hexahistidine (6×His) tag (31). Mouse PLC-
η1 (GenBank accession number BC055005) was obtained from ATCC (catalog number
9887980) and subcloned into the pcDNA4 vector at the 5′ EcoRI and 3′ AgeI sites with a
carboxy-terminal 6×His tag. The DNA sequence of human PLC-β2 was cloned into the
pcDNA3.1 vector at the 5′ EcoRI and 3′ XbaI sites (25). The sequence corresponding to human
PLC-β2 lacking the Gαq-interacting carboxy terminus was cloned into the pFastbac HTc vector
as previously described (21).
Purification of PLC-η2
The DNA sequence of human PLC-η2 corresponding to amino acids 42–872 [PLC-η2(PH-
C2)] or corresponding to amino acids 168–872 [PLC-η2(EF-C2)] was subcloned into the
pFastbac HTa vector at the 5′ EcoRI and 3′ XbaI sites with a 6×His tag and TEV (tobacco etch
virus) cleavage site engineered at the amino terminus. Conditions for expression and
subsequent purification of these two different forms of PLC-η2 were essentially identical.
Thus, recombinant baculovirus for PLC-η2(PH-C2) or PLC-η2(EF-C2) was used to infect
HighFive insect cells at a multiplicity of infection of 1. After 48 h of incubation at 27 °C, cells
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were harvested by low-speed centrifugation at 700g for 15 min at 4 °C and resuspended in
buffer A [20 mM Hepes (pH 8), 400 mM NaCl, 1 mM CaCl2, 15 mM imidazole, 10 mM 2-
mercaptoethanol, 5% glycerol, and protease inhibitor tablet (Roche)]. Cells were then lysed
with an EmulsiFlex C5 cell homogenizer (Avestin), and the lysate was subjected to
centrifugation at 100000g for 55 min. The clarified supernatant was filtered through a 0.2 µm
bottle top filter (Fisher Scientific). Ni-NTA resin (1 mL of resin/L of culture) was added to the
filtered supernatant, which was directly poured into a chromatography column. The flow-
through was collected and passed over the column two more times to increase the level of
protein binding with Ni resin. The column was then washed with 20 bed volumes of buffer A.
The 6×His-tagged PLC-η2 was eluted with 2 bed volumes of buffer B (buffer A with 150 mM
imidazole). The PLC-containing fractions of the eluant were combined, loaded onto a Superdex
200 gel filtration column, and subjected to resolution by fast protein liquid chromatography.
Samples were eluted in buffer C [20 mM Hepes (pH 8), 150 mM NaCl, 1 mM CaCl2, 10 mM
2-mercaptoethanol, and 10% glycerol].
Purification of Recombinant Gβ1γ2, Gαi1, and GRK2-ct
Recombinant baculoviruses encoding 6×His-Gαi1, Gβ1, and Gγ2 were used to co-infect
HighFive cells at a multiplicity of infection ratio of 0.7 (6×His-Gαi1):0.35 (Gβ1):0.26 (Gγ2).
After 48 h of incubation at 27 °C, cells were harvested by low-speed centrifugation and
resuspended in buffer I [20 mM Hepes (pH 8), 100 mM NaCl, 10 mM EDTA, 2 mM MgCl2,
10 mM 2-mercaptoethanol, 10 µM GDP, and protease inhibitor tablet]. Cells were then lysed
with an EmulsiFlex C5 cell homogenizer (Avestin), and the lysate was subjected to
centrifugation at 100000g for 55 min. The particulate membrane fraction was resuspended in
buffer II [20 mM Hepes (pH 8), 100 mM NaCl, 1 mM MgCl2, 10 mM 2-mercaptoethanol, 10
µM GDP, and protease inhibitor tablet], dounce-homogenized by 25 strokes, and solubilized
with 1% sodium cholate at 4 °C for 1 h on a stir plate. The membrane extract was centrifuged
at 100000g for 55 min. The clarified supernatant was batch-loaded with Ni-NTA resin at 4 °
C for 3 h and poured over a column. The flow-through was collected, and the Ni resin was
washed with 50 mL (25 bed volumes) of buffer III [20 mM Hepes (pH 8), 300 mM NaCl, 0.5%
C12E10, 1 mM MgCl2, 10 mM 2-mercaptoethanol, 10 µM GDP, and 10 mM imidazole]
followed by 10 mL (5 bed volumes) of buffer IV [20 mM Hepes (pH 8), 100 mM NaCl, 0.2%
sodium cholate, 10 µM GDP, 10 mM 2-mercaptoethanol, 10 mM imidazole, and 1 mM
MgCl2]. The column was brought to room temperature for 15 min and further washed three
times with 2 mL (1 bed volume) of buffer IV (warmed to 30 °C). The Gβ1γ2 dimer was then
eluted with six separate additions of 2 mL (1 bed volume) of buffer V [20 mM Hepes (pH 8),
50 mM NaCl, 1% sodium cholate, 10 µM GDP, 10 mM 2-mercaptoethanol, 10 mM imidazole,
50 mM MgCl2, 10 mM NaF, 30 µM AlCl3, and protease inhibitor tablet, warmed to 30 °C],
and 6×His-GRi1 eluted with six separate additions of 2 mL (1 bed volume) of buffer VI [20
mM Hepes (pH 8), 100 mM NaCl, 1% sodium cholate, 10 µM GDP, 10 mM 2-mercaptoethanol,
150 mM imidazole, 1 mM MgCl2, and protease inhibitor tablet, warmed to 30 °C]. Two
fractions of Gβ1γ2-containing eluant were combined and concentrated using a VIVASPIN6
10000 molecular weight cutoff column (Sigma-Aldrich) in a swing bucket rotor centrifuged
at 2500 rpm according to the manufacturer’s protocol. The concentrated protein was passed
over a G-25 gel filtration column to exchange the sample into buffer VII [20 mM Hepes (pH
8), 100 mM NaCl, 0.7% sodium cholate, and 10 mM 2-mercaptoethanol]. The desalted material
was then concentrated as described above. Protein concentrations were determined by
comparison to a BSA standard on a Coomassie-stained SDS-PAGE gel. Gαi1 was purified in
the same fashion as described above except that infections were with baculoviruses for Gαi1
lacking a 6×His tag and with Gγ2 containing a 6×His tag. [35S]GTPγS binding assays were
carried out to confirm that the purified Gαi1 stoichiometrically bound GTP and, therefore, was
fully active.
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A bacterial expression plasmid (pER28a) encoding the PH domain of G protein-coupled
receptor kinase 2 (GRK2-ct; residues 548–641 with six C-terminal histidines) was a generous
gift from A. Bohm (Tufts University, Medford, MA). GRK2-ct was purified as we previously
described (20).
In Vitro PLC Assay
The enzyme activity of purified PLC-η2 and its potential regulation by Gβ1γ2 were quantified
using phosphatidylethanolamine (PE)- and PtdIns(4,5)P2-containing vesicles as previously
described in detail (32). Briefly, recombinant proteins were reconstituted with lipid vesicles
containing 50 µM PtdIns(4,5)P2 (unless otherwise indicated; Avanti Polar Lipids), 500 µM PE
(Avanti Polar Lipids), and ~8000 cpm of [3H]PtdIns(4,5)P2 (Perkin-Elmer) per assay. Final
buffer conditions were as follows: 20 mM Hepes (pH 7.2), 70 mM KCl, 3 mM EGTA, 2 mM
dithiothreitol, 0.16 mg/mL fatty acid-free bovine serum albumin, and 10 µM free Ca2+ in a
final volume of 60 µL. All reactions were carried out at 32 °C for 10 min (unless otherwise
indicated) and were terminated by the addition of 200 µL of 10% trichloroacetic acid and 100
µL of 10 mg/mL fatty acid-free bovine serum albumin. Centrifugation of the reaction mixture
separated aqueous [3H]Ins(1,4,5)P3 from precipitated [3H]-PtdIns(4,5)P2, and soluble [3H]Ins
(1,4,5)P3 was quantified by liquid scintillation counting.
For experiments determining the effects of Gβ1γ2 on phospholipase C activity, purified
Gβ1γ2 dimer in cholate detergent was combined with phospholipid vesicles, therein diluting
cholate to concentrations well below its critical micellar concentration. For experiments
determining the effects of Gαi1 on the capacity of Gβ1γ2 to activate PLC, 10 µL of purified
Gβ1γ2 and Gαi1 were combined in the presence of 10 µM GDP on ice for 20 min prior to lipid
vesicle reconstitution. For experiments determining the effects of GRK2-ct on the Gβ1γ2-
mediated activation of PLC, 10 µL of purified Gβ1γ2 and GRK2-ct were combined on ice for
20 min prior to lipid vesicle reconstitution.
Quantification of PLC Activity in COS-7 Cells
COS-7 cells were seeded in 12-well plates at a density of 65000 cells per well and maintained
in DMEM (Dulbecco’s modified Eagle’s medium) supplemented with 10% (v/v) fetal bovine
serum at 37 °C in an atmosphere of 90% air and 10% CO2. Three hundred nanograms of PLC-
β2, 100 ng of PLC-η2(2–23), 100 ng of PLC-η2(PH-C2), or 300 ng of PLC-η1 plasmid DNA
was transfected into COS-7 cells in the absence or presence of 200 ng each of expression vectors
for Gβ and Gγ subunits using Fugene 6 (Roche) transfection reagent according to the
manufacturer’s protocol. The medium was changed to inositol-free DMEM containing 1 µCi
of [3H]inositol per well 24 h after transfection. After incubation for an additional 18 h, [3H]
inositol phosphate accumulation was initiated by addition of LiCl to a final concentration of
50 mM. The reaction was stopped after 60 min by aspiration of the medium and the addition




With the goal of determining whether Gβγ subunits of heterotrimeric G proteins directly
regulate PLC-η2, we initiated studies to purify the isozyme to homogeneity. However, multiple
attempts to purify full-length PLC-η2 after expression from a baculovirus in insect cells yielded
insuf- ficient amounts of purified protein, and two major degradation products of PLC-η2 were
observed. Therefore, we considered whether Gβ1γ2-dependent regulation of a truncated form
(s) of PLC-η2 occurred in intact cells, whether this truncated PLC-η2 protein(s) could be
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purified in adequate yield to be studied with phosphoinositide-containing vesicles, and whether
direct Gβ1γ2-dependent activation could be observed with the purified isozyme.
Activation of PLC-η2 by Gβγ in COS-7 Cells
A mammalian expression vector was generated for a truncated version of PLC-η2 that
encompassed the PH domain through C2 domain [amino acids 42–872 (Figure 1A)]. This
truncated PLC-η2 was expressed in COS-7 cells, and its potential regulation by Gβ1γ2 was
examined by cotransfection of cells with expression vectors for Gβ1 and Gγ2. As illustrated in
Figure 1B, marked Gβγ-dependent increases in inositol phosphate accumulation occurred in
cells also expressing the truncated form of the isozyme, and the extent of activation of PLC-
η2(PH-C2) by Gηβ1γ2 was similar to that of PLC-η2(2–23), but lower than the activity
observed when Gβ1γ2 was coexpressed with PLC-β2.
Given the similarity in sequence between PLC-η2 and PLC-η1, we also tested whether
Gβ1γ2 activates both members of this subfamily of PLC isozymes. As illustrated in Figure 1B,
no Gβ1γ2-dependent increase in inositol phosphate accumulation occurred in cells
coexpressing PLC-η1. Similar results were observed with transfection of a wide range of
amounts of PLC-η1 DNA (data not shown). COS-7 cells overexpressing PLC-η1 or PLC-η2
were harvested 48 h after transfection. Immunoblots revealed that similar levels of expression
of PLC-η1 and PLC-η2 occurred under the conditions of these experiments, and furthermore,
coexpression of Gβ1γ2 did not alter the expression level of either PLC-η1 or PLC-η2 isozyme
(data not shown). Therefore, we conclude within the limitations of transfection experiments
that PLC-η2, but not PLC-η1, is subject to regulation by Gβ1γ2.
The possibility that Gβγ dimers in addition to Gβ1γ2 activate PLC-η2 also was examined in
COS-7 cells transfected with equal amounts of DNA for expression of various Gβγ dimers
(Gβ2γ2, Gβ3γ2, Gβ4γ2, and Gβ5γ2). Immunoblots illustrated similar levels of expression of all
five different Gβxγ2-containing dimers tested, although the level of expression was
reproducibly slightly higher with Gβ1γ2 (data not shown). The strongest activation of both
PLC-η2 and PLC-β2 was observed with Gβ1γ2 (Figure 2), and the pattern of relative activities
observed with the other Gβγ dimers was similar for PLC-η2 versus PLC-β2. Thus, Gβ2γ2 and
Gβ4γ2 activated both PLC isozymes, whereas no reproducible activation was observed with
Gβ3γ2. Gβ5γ2 slightly activated PLC-β2, but no reproducible activation of PLC-η2 was
observed with this G protein dimer.
Purification of PLC-η2(PH-C2)
Given that Gβ1γ2-mediated regulation of PLC-η2 was retained in COS-7 cells in studies with
a truncated version of this isozyme, we constructed a recombinant baculovirus for expression
of a protein that encompasses the PH through the C2 domain [amino acids 42–872 (Figure
1A)] of PLC-η2. PLC-η2(PH-C2) was expressed at high levels without observable degradation
products and was readily purified after overexpression in HighFive insect cells as described in
Materials and Methods. Yields of purified protein averaged 5 mg/L of infected cells with
approximately 90% purity obtained in a single Ni-NTA affinity purification step. Analyses of
this purified fraction by size exclusion chromatography revealed that greater than 50% of PLC-
η2 existed as soluble aggregates. Therefore, a Superdex 200 size-exclusion chromatography
step was included in the standard protocol for purification of active PLC-η2. The final purified
isozyme migrated as a monomer of the predicted size (approximately 100 kDa) and was
essentially homogeneous as assessed by Coomassie staining of SDS-PAGE gels (Figure 3A
inset). Assessment with a PLC-η2-specific antibody also indicated that little or no proteolysis
of PLC-η2(PH-C2) occurred (data not shown).
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Enzymatic Properties of Purified PLC-η2(PH-C2)
Purified PLC-η2(PH-C2) exhibited marked phospholipase C activity in assays using mixed
detergent phospholipid micelles containing 50 µM [3H]PtdIns(4,5)P2 as a substrate.
Phosphoinositide hydrolysis was linear for at least 10 min under these assay conditions (Figure
3A) and was proportional to the amount of purified enzyme used over a wide range of
concentrations (data not shown). Kinetic analysis of PLC-η2(PH-C2)also was performed using
PE-and[3H]PtdIns(4,5)P2-containing vesicles presented at various concentrations in the bulk
medium in the absence of detergent. Assays carried out under these conditions with PLC-η2
(PH-C2) revealed a Vmax of 12.6 µmol min−1 mg−1 and an apparent Km for PtdIns-(4,5)P2 of
14.4 µM (Figure 3B).
Activation of Recombinant PLC-η2 by Gβ1γ2
Gβ1γ2 directly activates PLC-β2 and PLC-β3, and although Gβ1γ2 also stimulates PLC-ε-
dependent increases in inositol phosphate accumulation in intact cells (25), we have been
unable to observe direct activation of several truncated constructs of PLC-ε in in vitro
reconstitution assays. To determine whether Gβ1γ2 directly activates PLC-η2, Gβ1γ2 was
expressed from recombinant baculoviruses in insect cells, purified to near homogeneity from
detergent-extracted membranes (Figure 4A inset), and reconstituted in substrate-containing
phospholipid vesicles. The capacity of 500 nM Gβ1γ2 to activate PLC-η2(PH-C2) was
compared to its capacity to activate PLC-β2(PH-C2). The basal level of PtdIns(4,5)P2
hydrolysis was consistently higher in the presence of PLC-η2(PH-C2) than in the presence of
PLC-β2(PH-C2), suggesting that PLC-η2 may exhibit less auto-inhibition (or basally interact
with substrate-containing membranes more effectively) than PLC-β2. Coreconstitution with
Gβ1γ2 resulted in increased activities of both isozymes, although the fold stimulation was
greater for PLC-β2(PH-C2) than for PLC-η2(PH-C2) (Figure 4A).
Gβ1γ2 was reconstituted in phospholipid vesicles over a wide range of concentrations (Figure
4B), and Gβ1γ2-dependent increases in PtdIns(4,5)P2 hydrolysis were observed with both
purified PLC-η2(PH-C2) and purified PLC-β2(PH-C2). Half-maximal activation occurred at
a concentration of Gβ1γ2 of 284 ± 94 nM (n = 3 experiments) for PLC-η2(PH-C2) and at 98 ±
23 nM (n = 3 experiments) for PLC-β2(PH-C2).
To establish that the effects observed with Gβ1γ2 represented effector activation that depended
on the presence of free Gβγ dimer, the natural binding partner of Gβγ, Gαi1, was purified after
expression in HighFive cells (Figure 5A inset) and reconstituted in substrate-containing
phospholipid vesicles with purified Gβ1γ2 in the presence of GDP. As illustrated in Figure 5A,
Gβ1γ2-dependent stimulation of phospholipase activity of PLC-η2(PH-C2) was inhibited to
basal levels in the presence of GDP-bound Gαi1, suggesting that the activation of PLC-η2(PH-
C2) was indeed Gβγ-specific. Similar effects of Gαi1 on Gβ1γ2-stimulated PLC-β2 activity
were observed. Gαi1 was further reconstituted over a wide range of concentrations in
phospholipid vesicles with a fixed amount of Gβ1γ2. The addition of Gαi1 inhibited Gβ1γ2
activation of both PLC-η2(PH-C2) and PLC-β2(PH-C2) in a concentration-dependent manner
(Figure 5B). The curve for Gαi1-mediated reversal of activation of PLC-η2(PH-C2) was shifted
to the left compared to that for inhibition of PLC-β2(PH-C2) activation, which was consistent
with the fact that higher concentrations of Gβ1γ2 were necessary for activation of PLC-η2(PH-
C2) compared to PLC-β2(PH-C2).
To further confirm the selectivity of Gβγ activation, GRK2-ct (amino acids 495–689) was
employed in the reconstitution assay as another protein that binds Gβγ and, thereby, potentially
inhibits activation of effector enzymes that is dependent on the presence of free Gβγ. As shown
in Figure 6, the addition of GRK2-ct reversed the activation of both PLC-η2 and PLC-β2 by
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Gβ1γ2 to basal levels, and it did so in a concentration-dependent manner. Thus, GRK2-ct
sequesters free Gβγ, and therefore, Gβγ-mediated activation of PLC-η2 is lost.
Previous studies with PLC-β2 have implicated the PH domain in activation of this isozyme by
Gβγ (19–21). Therefore, a construct of PLC-η2 that eliminates this conserved domain and
encompasses the EF-hand repeats through the C2 domain [amino acids 168–872 (Figure 1A)]
was produced, and PLC-η2(EF-C2) was purified to homogeneity (Figure 3A inset) as described
in Materials and Methods. Kinetic analyses using addition of different amounts of PtdIns(4,5)
P2 substrate in the bulk medium revealed that the lipase activity (Vmax = 7.8 µmol min−1
mg−1) of purified monomeric PLC-η2(EF-C2) was similar to that of PLC-η2(PH-C2), although
the observed Km (approximately 50 µM) for PtdIns(4,5)P2 was higher (data not shown). As
illustrated in Figure 7, Gβ1γ2 also activated this PLC-η2 lacking the PH domain, and therefore,
we conclude that activation by this G protein heterodimer occurs at least in part through
interaction with the catalytic core of the isozyme.
DISCUSSION
The work described here illustrates direct, concentration-dependent stimulation of purified
PLC-η2 in phospholipid vesicles reconstituted with purified Gβ1γ2. Gβγ-dependent activation
of PLC-η2 also is observed in intact cells with multiple forms of the heterotrimeric subunit.
Thus, we have identified a novel effector of Gβγ and have implicated this PLC isozyme in
signaling responses downstream of heterotrimeric G protein-coupled receptors.
The involvement of multiple G proteins in receptor-promoted regulation of inositol lipid
signaling was first realized in studies of the PLC-β isozymes. Gα subunits of the Gq family
initially were shown to mediate guanine nucleotide-dependent activation (12–15), but
subsequent studies revealed that PLC-β2 and PLC-β3 also are activated by Gβγ subunits of
heterotrimeric G proteins (16–18). The apparent complexity of G protein-dependent regulation
of inositol lipid signaling was further increased by realization that the small GTPase Rac binds
and activates PLC-β2 (19–21). Moreover, the most divergent member of the PLC isozyme
family, PLC-ε, was initially discovered as a Ras-binding protein in Caenorhabditis elegans,
and the mammalian isoform is dually activated by Ras (22–24) and Rho (26,27) through direct
binding of these GTPases to two different regions of the isozyme. Although PLC-γ isozymes
are activated by phosphorylation by receptor and other tyrosine kinases, PLC-γ2 is additionally
activated by Rac (11). Transient expression studies in intact COS-7 cells implicated activation
of PLC-η2 by Gβγ subunits, and the results presented here illustrate that this novel PLC isozyme
is a direct effector of Gβγ.
We previously screened all of the heterotrimeric Gα subunits and many Ras superfamily
GTPases for stimulation of PLC-η2 after coexpression in COS-7 cells, and only Gβγ was
identified as a potential activator of the isozyme (31). Additional comprehensive analyses are
needed, but within the limitations of our screens to date, PLC-η2 is the only PLC isozyme that
is solely regulated by Gβγ. Thus, our data are consistent with the idea that G protein-coupled
receptors activate PLC-η2 by release of Gβγ from heterotrimeric G proteins. The broad
expression of PLC-η2 in the brain together with the high levels of neuronal Gαo and other
members of the Gi subfamily suggests that this PLC isozyme may in part function downstream
of Gi-coupled receptors in the neuronal signaling pathways. For example, PLC-η2 is strongly
expressed in hippocampus, cerebral cortex, and olfactory bulb in mouse brain (30). Expression
of PLC-η2 was detected in early developmental stages in mouse brain and was proposed to be
important in formation and/or maintenance of the neuronal networks in postnatal brain (30).
The exact roles of G protein-mediated regulation of PLC-η2 in brain development await further
exploration.
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Gβ1γ2 was the only G protein dimer tested as an activator of purified PLC-η2. However, the
relative effects of Gβγ subunits of various subunit composition on PLC-η2-versus PLC-β2-
promoted activity were very similar in transfection studies, and therefore, it is unlikely that
remarkable differences exist in the selectivity of regulation of these two PLC isozymes by
certain Gβγ subunits. Given its similarity in sequence with PLC-η2, we also tested whether
Gβ1γ2 activates PLC-η1. Multiple coexpression experiments with COS-7 cells carried out
under a variety of conditions failed to reveal any Gβγ-dependent activation of PLC-η1. Thus,
within the limitations of these transfection experiments, we conclude that Gβγ differentially
regulates the two PLC-η isozymes. Whether PLC-η1 is regulated by small GTPases or by other
heterotrimeric G protein subunits remains unreported.
The last three exons of the PLC-η2 gene are alternatively spliced in both mice and humans to
produce at least four splice variants containing markedly variable C-terminal domains beyond
the C2 domain (31). The physiological relevance of these different forms of PLC-η2 is not yet
known, but as illustrated here, removal of the 545 C-terminal amino acids does not
demonstrably affect its regulation by Gβ1γ2. Previous studies have suggested that Gβγ interacts
with multiple sites in PLC-β2, and both the catalytic and PH domains have been implicated in
Gβγ-dependent activation of the isozyme (19,35–37). A construct of PLC-η2 that encompassed
the PH through C2 domain retained activation by Gβ1γ2 both in vivo and in vitro, but
observation of similar levels of activation of a fragment of PLC-η2 lacking the PH domain
indicates that in contrast to PLC-β2, the PH domain of PLC-η2 appears to be relatively
unimportant in Gβ1γ2-mediated regulation. However, Nakahara and co-workers (30) illustrated
that PLC-η2 is predominantly associated with the plasma membrane in mouse brain and
reported that the PH domain is necessary for membrane localization.
The mechanism by which Gβγ activates PLC-β isozymes, and now PLC-η2, remains to be
defined. Activation could follow from simple Gβγ-dependent recruitment to phosphoinositide
substrate-containing membranes, or activation may involve G protein-promoted
conformational changes in the catalytic core of the enzyme. Mechanistic insight into the
activation of PLC isozymes has accrued from our recent structural and biochemical studies
illustrating that PLC-β2 and, ostensibly, PLC-δ and PLC-ε are autoinhibited by the unstructured
X–Y linker region of the isozymes (ref 21 and unpublished observations of S. Hicks et al.,
2007). These studies strongly suggest that the active site-occluding X–Y linker moves as a
consequence of dense negative charges in the linker encountering negatively charged
membrane surfaces; autoinhibition is relieved, and access to the PtdIns(4,5)P2 substrate is
promoted. Thus, our structures of PLC-β2 alone and PLC-β2 in a GTP-dependent complex
with Rac1 illustrate that Rac-mediated activation of PLC-β2 follows from simple recruitment
of the enzyme to membrane surfaces. In contrast, biochemical studies of Gβγ- dependent
activation of PLC-β2 suggest a more complex mode of regulation involving the catalytic core
of the enzyme, and therefore, the mechanism(s) by which Gβγ activates PLC-β2 and other PLC
isozymes remains unclear. The Gβγ-binding interface has not yet been structurally identified
in any PLC isozyme, and it will be important to establish unambiguously whether Gβγ binds
to PLC-η2 and PLC-β2 through similar or different determinants.
A notable difference between PLC-η2 and PLC-β2 is that the overall charge of PLC-η2 is much
more positive than that of PLC-β2, and the X–Y linker of PLC-η2 is essentially devoid of
sequence containing dense negative charge and overall is positively charged. Thus, we
anticipate that PLC-η2 exhibits less autoinhibition and greater electrostatic force-dependent
attraction to phosphoinositide substrate-containing membrane surfaces. Such properties may
explain the high basal activity of PLC-η2, and given these differences in PLC-β2 and PLC-
η2, it is perhaps not surprising that the fold activation of PLC-β2 by Gβ1γ2 was greater than
that observed with PLC-η2. Nomikos and co-workers (38) recently concluded that a dense
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positive region in the X–Y linker of PLC-ζ also is important for membrane association and
activity of this sperm-specific isozyme.
In conclusion, we have demonstrated that Gβ1γ2 directly activates PLC-η2. Future experiments
will delineate the region of Gβ1γ2 interaction and reveal the mechanism of activation. The
physiological role of Gβ1γ2-mediated activation of PLC-η2 is under investigation.
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Activation of PLC-η2 by the G protein Gβ1γ2 dimer. (A) Schematic representation of PLC-η2
(2–23) (residues 42–1416, top), PLC-η2(PH-C2) (residues 42–872, middle), and PLC-η2(EF-
C2) (residues 168–872, bottom). PLC-η2(2–23) (exon 2–23) is an alternative splice variant
that lacks the first exon (41 amino acids) of human PLC-η2 (GenBank accession number
DQ176850). PLC-η2(PH-C2) lacks the C-terminal 545 amino acids of PLC-η2(2–23); PLC-
η2(EF-C2) additionally lacks the N-terminal PH domain. (B) PLC-η2(2–23), PLC-η2(PH-C2),
or mouse PLC-η1 was coexpressed as described in Materials and Methods with Gβ1γ2. [3H]
Inositol phosphate accumulation was measured as described in Materials and Methods. PLC-
β2 was coexpressed with Gβγ as a positive control. The results are presented as means ± SEM
for triplicate determinations and are representative of results from three or more separate
experiments.
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Activation of PLC-η2 by various G protein Gβγ dimers. PLC-η2(2–23) or PLC-β2 was
coexpressed as described in Materials and Methods with Gβ1γ2, Gβ2γ2, Gβ3γ2, Gβ4γ2, or
Gβ5γ2. [3H]Inositol phosphate accumulation was measured as described in Materials and
Methods. The results are presented as means ± SEM for triplicate determinations and are
representative of results from three or more separate experiments.
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Characterization of the phospholipase activity of PLC-η2(PH-C2). (A) Time course of PtdIns
(4,5)P2 hydrolysis in the presence of 1 ng of PLC-η2(PH-C2). (B) Lipase activity of 1 ng of
PLC-η2(PH-C2) assayed with increasing concentrations of PtdIns(4,5)P2 substrate. The data
are the means ± the standard error of three individual experiments. The inset shows a
Coomassie-stained SDS–PAGE gel of purified PLC-η2(PH-C2) and PLC-η2(EF-C2).
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Activation of PLC-η2(PH-C2) by purified Gβ1γ2. Recombinant Gβ1γ2 at 500 nM (A) or at
various concentrations (B) was reconstituted in phospholipid vesicles as described in Materials
and Methods. PLC-η2(PH-C2) or PLC-β2(PH-C2) was added, and the assay was performed
at 32 °C for 10 min. The data from multiple experiments were transformed and pooled by
subtracting basal activities (2–4 pmol min−1 ng−1 for PLC-η2 and 0.5–1 pmol min−1 ng−1 for
PLC-η2) from maximal Gβ1γ2-stimulated activities (6–9 pmol min−1 ng−1 for PLC-η2 and 12–
15 pmol min−1 ng−1 for PLC-β2) to provide values for “maximal activation”. Identically
calculated values for each concentration of Gβ1γ2 were then divided by the values for maximal
activation to provide values for “percent maximal activation”. The results presented are the
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means ± the standard error of three separate experiments. The inset shows recombinant
Gβ1γ2 purified from detergent-extracted HighFive insect cell membranes. Proteins were
resolved by SDS–PAGE and stained with Coomassie blue.
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Gαi1-dependent inhibition of Gβ1γ2-promoted activation of PLC-η2(PH-C2). Recombinant
Gαi1 at 2 µM (A) or various concentrations (B) was reconstituted with 1 µM Gβ1γ2 in
phospholipid vesicles as described under Materials and Methods. PLC-η2(PH-C2) (1 ng) or
PLC-β2(PH-C2) (5 ng) was added, and the assay was performed at 32 °C for 10 min. The data
from multiple experiments were transformed and pooled by subtracting basal activities (2–4
pmol min−1 ng−1 for PLC-η2 and 0.5–1.0 pmol min−1 ng−1 for PLC-β2) from activities (6–9
pmol min−1 ng−1 for PLC-η2 and 12–15 pmol min−1 ng−1 for PLC-β2) observed in the presence
of 1 ηMGβ1γ2 to provide values for maximal activation. Identically calculated values were
obtained for each combination of 1 µMGβ1γ2 with the indicated concentrations, and these
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values were divided by that for maximal activation to provide a value for percent maximal
activation. The results presented are the means ± the standard error of three separate
experiments. The inset shows recombinant Gαi1 purified from detergent-extracted HighFive
insect cell membranes, resolved by SDS–PAGE, and stained with Coomassie blue.
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GRK2-ct-mediated reversal of Gβ1γ2-promoted activation of PLC-η2(PH-C2). Increasing
concentrations of GRK2-ct were reconstituted with 1 µMGβ1γ2 in phospholipid vesicles as
described in Materials and Methods. PLC-η2(PH-C2) (5 ng) or PLC-β2(PHC2) (5 ng) was
added, and the assay was performed at 32 °C for 10 min. The data from multiple experiments
were transformed and pooled by subtracting basal activities (2–4 pmol min−1 ng−1 for PLC-
η2 and 0.5–1.0 pmol min−1 ng−1 for PLC-β2) from activities (6–9 pmol min−1 ng−1 for PLC-
η2 and 12–15 pmol min−1 ng−1 for PLC-β2) observed in the presence of 1 µM Gβ1γ2 to provide
values for maximal activation. Identically calculated values were obtained for each
combination of 1 µM Gβ1γ2 with the indicated concentrations, and these values were divided
by that for maximal activation to provide a value for percent maximal activation. The results
presented are the means ± the standard error of three separate experiments.
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Retention of Gβ1γ2-mediated activation in a purified construct of PLC-η2 lacking the PH
domain. Recombinant Gβ1γ2 at 500 nM was reconstituted in phospholipid vesicles with PLC-
η2(PH-C2) or PLC-η2(EF-C2). The assay was performed at 32 °C for 10 min. The results
presented are the means ± the standard error of three separate experiments.
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